Home Tags CD30-expressing relapsed or refractory diffuse large B-cell lymphoma

Tag: CD30-expressing relapsed or refractory diffuse large B-cell lymphoma

Phase II Clinical Trial of Brentuximab Vedotin Combination Therapy in...

Based on encouraging data in patients with CD30-expressing relapsed or refractory diffuse large B-cell lymphoma or DLBCL, the most common type of aggressive non-Hodgkin Lymphoma...

X